Stephen C. Glover insider trades
Open-market stock purchases and sales by Stephen C. Glover, Director at Oncolytics Biotech Inc, from SEC Form 4 filings since Dec 12, 2022.
Open-market stock purchases and sales by Stephen C. Glover, Director at Oncolytics Biotech Inc, from SEC Form 4 filings since Dec 12, 2022.